Recall Radar

Disclaimer: Recall Radar is an informational summary of public FDA enforcement reports. It is not medical advice. Always confirm details with the FDA, the company, a pharmacist, or a doctor before making health decisions.

← All recalls · Drug recalls

Not Yet ClassifiedDrug

amazon recall

Summary

Aurobindo Pharma USA Inc is recalling amazon (drug). According to the FDA report, the reason is: Discoloration: consumer complaints received for discolored tablets. The FDA rated this a Not Yet Classified: Recall status: Ongoing.

Details from the FDA report

Product
amazon, Acetaminophen, Extra Strength, 500mg Caplets, 1000-count bottle, Distributed by: Amazon.com Services LLC, 410 Terry Avenue N., Seattle, WA 98109, Made in India, NDC 72288-692-01. UPC 1 95515 04888 0
Reason
Discoloration: consumer complaints received for discolored tablets
Lot / code info
Lot# ACD124048A, Exp Date: 11/30/2027.
Quantity
7,836 1000-count bottles
Distribution
US Nationwide.
Recalling company
Aurobindo Pharma USA Inc, East Windsor, NJ United States
Recall started
September 18, 2026
FDA report date
October 7, 2026
Classification
Not Yet Classified:
Voluntary / mandated
Voluntary: Firm initiated
Status
Ongoing
Recall number

What to do

View the FDA source record (openFDA) · FDA recalls page

Helpful guides

All guides

Get recall alerts by email

One short digest when new FDA food, supplement or drug recalls are posted, with the most serious (Class I) first. Free; unsubscribe anytime.

Powered by Buttondown. You may need to confirm your address by email.